Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candid…
Drug Manufacturers - Specialty & Generic
US, San Diego [HQ]
Strategy & Leadership
All directors and officers of Adamis Pharmaceuticals Corporation are sourced directly from the SEC or manually.
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).
Each datapoint refers the most recent appearance of the corresponding person.
Officers & BofD Beta
For the SEC we either use the Form 3/4/5 or, even better extract the compensation for each leader out of the audited proxy statement (DEF-14A).
Total Compensation
Shows the total compensation per mentioned executive and board director.Each datapoint refers the most recent appearance of the corresponding person.
- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position | Research | Last Appearance | ||
---|---|---|---|---|
Dorbin John W. Jr.
General Counsel
|
11/02/23 [Form 4]
|
|||
Cohen Seth
CFO
|
10/25/23 [Form 4]
|
|||
Versi Ebrahim
CEO
Also inside the BofD
|
09/19/23 [Form 4]
|
|||
Moss Ronald B.
Chief Medical Officer
|
03/22/22 [Form 4]
|
|||
Marguglio David J.
SVP and Chief Business Officer
Also inside the BofD
|
03/22/22 [Form 4]
|
|||
Carlo Dennis J Phd
President & CEO
Also inside the BofD
|
03/22/22 [Form 4]
|
|||
Benedicto David C.
Chief Financial Officer
|
03/22/22 [Form 4]
|
|||
Hopkins Robert O
Chief Financial Officer
|
02/23/21 [Form 4]
|
|||
Daniels Karen K.
VP of Operations
|
02/16/21 [Form 5]
|
Board of Directors (BofD)
Name & Position | Research | Last Appearance | ||
---|---|---|---|---|
Desai Meera J.
Director
|
05/30/23 [Form 4]
|
|||
Versi Jannine
Director
|
05/30/23 [Form 4]
|
|||
Birndorf Howard C
Director
|
11/16/22 [Form 4]
|
|||
Reed Vickie S
Director
|
05/26/22 [Form 3]
|